Mal de Meleda, also known as keratoderma palmoplantaris transgrediens, is a rare type of autosomal recessive palmoplantar keratoderma. A 19-year-old male presented with a congenital yellowish discoloration and thickening of both palms and soles of the feet. His family history revealed that there was no consanguinity between the mother and the father and that the patient had three healthy brothers. The second-and third-degree relatives, five females and one male, also exhibited similar skin findings. From the isolated DNA samples, the extrinsic regions of the SLURP1 gene were screened using the sequence analysis and the Sanger sequencing was performed with the 3130 Sequence Analyzer. Results of this analysis show that a p.Arg 96 Pro (R96P) (c.287 CGA>CCA) homozygous missense point mutation was detected on the SLURP 1 (a secreted toxin-like mammalian lymphocyte antigen 6/urokinase-type plasminogen activator receptor-related protein 1) gene of the patients, while heterozygous p.Arg 96 Pro (R96P) (c.287 CGA>CCA) mutation was detected in the mother, father, and brothers. Our search of the Human Genome Mutation Database and previous literature revealed no reports of this mutation in mal de Meleda. We report this case due to the identification of a novel gene mutation in a patient with mal de Meleda, a palmoplantar keratoderma.
Introduction
Mal de Meleda, also known as keratoderma palmoplantaris transgrediens, is a rare type of autosomal recessive palmoplantar keratoderma [1] . It was first described in 1826 in a patient from Mljet, formerly known as the Meleda Island in the Adriatic Sea. The prevalence of this extremely rare disease is 1/1,000,000 [2, 3] . Since its discovery in 1826, the disease has been reported in at least 19 countries in addition to Croatia. These include Algeria, Chile, China, Germany, India, Indonesia, Italy, Japan, Korea, Laos, Libya, The Netherlands, Pakistan, Saudi Arabia, Scotland, Sweden, Tunisia, Turkey, and the United Arab Emirates [2] .
We report a case of a 19-year-old male diagnosed with mal de Meleda, in whom a novel gene mutation was identified.
Case Presentation
A 19-year-old male presented with a congenital yellowish discoloration and thickening of both palms and soles of the feet. His only other symptoms were hyperhidrosis and foul odor in the hands and feet. His previous medical history was unremarkable. His family history revealed that there was no consanguinity between the mother and the father and that the patient had three healthy brothers. The second-and third-degree relatives, five females and one male, also exhibited similar skin findings. Patient' s family tree is shown in Figure 1 . No pathology was observed on the systemic examination. A dermatological examination revealed bilateral palmoplantar pointed pits, maceration, and foul odor between the toes on slightly erythematous yellowish hyperkeratotic areas extending to the dorsal aspect of the hands and feet (Figure 2 ). An examination of the hair, teeth, and mucosa was unremarkable. Subungual hyperkeratosis and dystrophic changes were found in the nails. The hands and toes were free of contractures, and there was no motion limitation observed. Routine laboratory analyses were within the normal limits. Hyphae and spores were observed upon a direct KOH analysis of samples prepared from palms We collected blood samples from 4 individuals, including our patient, and performed genomic DNA isolation. Three pairs of primers were used for the SLURP1 gene. These primers included 1F: 5'GAACAGTGAGTTCCCCAGTG 3', 1R: 5'CACTGAGAATGAGGAGGGTG 3', 2F: 5'GATGTCAGCGAGACTCCTTC 3', 2R: 5'CAGGACTGGGTCTCTGAG 3', 3F: 5'GAA-CAGGGATCACAGGGAG 3', and 3R: 5'GT-CATGTCCACTCTTGGCTT 3', respectively. From the isolated DNA samples, the extrinsic regions of the SLURP1 gene were screened using the sequence analysis, and Sanger sequencing was performed with the 3130 Sequence Analyzer.
The results of this analysis show that a p.Arg 96 Pro (R96P) (c.287 CGA>CCA) homozygous missense point mutation was detected on the SLURP1 gene of the patients, while a heterozygous p.Arg 96 Pro (R96P) (c.287 CGA>CCA) mutation was detected in the mother, father, and brothers (Figure 4) . Our search of the Human Genome Mutation Database and previous literature revealed no previous report of this mutation in mal de Meleda.
Discussion
Mal de Meleda, a hereditary palmoplantar keratoderma, is characterized by symmetrical palmoplantar keratoderma and hyperkeratosis covering the dorsal surface of the hands and feet in a glove/sock form, occurring at birth or within a few years after birth [3] . In addition to these findings, patients have also presented with hyperhidrosis in the palms and soles of the feet; pointed pits in palmoplantar keratoderma areas; perioral erythema; brachydactyly; nail disorders; progressive, conical, thinning; contracture and pseudoarthritic developments on the fingertips; and cleft palate [3] [4] [5] . Our patient presented with hyperhidrosis in palms and soles of the feet, pointed pits in palmoplantar keratoderma areas, and subungual hyperkeratosis.
Autosomal recessive palmoplantar keratodermas should be considered during differential diagnosis of mal de Meleda. Among these, the Papillon-Lefèvre syndrome is characterized by periodontitis and premature teeth loss [6] . Our patient' s teeth were normal in appearance. Hyperkeratosis, which was observed on the dorsal surfaces of our patient' s hands and feet and mild erythema also helped to differentiate it from the autosomal dominant Thost-Unna keratoderma [3] . The absence of mental retardation and corneal dystrophy distinguished it from the Richner-Hanhart syndrome, while the absence of periorificial verrucous papules and hyperkeratosis distinguished it from the Olmsted syndrome. A honeycomb pattern and star-like hyperkeratosis, deafness, spontaneous amputations, and the absence of ichthyosis distinguished it from the autosomal dominant Vohwinkel syndrome; the absence of concomitant esophageal malignancy and oral mucosal lesions distinguished it from the Howel-Evans syndrome; while the absence of woolly hair and cardiac anomalies helped to distinguish it from Mal de Naxos [2, [5] [6] [7] [8] .
In 2001, the pathogenesis of mal de Meleda was reported to be due to the ARS (component B) gene mutation encoding SLURP1 in the chromosome 8q24.3 region [9] . In addition to its role as a neuromodulator regulating epidermal homeostasis, the SLURP1 protein is also known to inhibit the secretion of tumor necrosis factor alpha from macrophages during wound healing. These roles also explain the hyperproliferative and inflammatory processes reflected in the clinical manifestation of mal de Meleda [1] . Examination of the DNA material obtained from patient' s blood sample revealed a p.Arg 96 Pro (c.287 CGA>CCA) homozygous missense mutation in the SLURP1 gene. No case of mal de Meleda with this mutation was encountered in our scan of the previous literature.
Mal de Meleda, with its chronic course, is difficult to treat. Topical keratolytic agents are usually used [7] . A treatment with systemic retinoids, 5-fluorouracil infusion, and bath PUVA has also been reported to be very effective [10, 11] . However, the symptoms may resurface when treatment is discontinued. Treatment should be supplemented with antibacterial and antifungal medication due to an increased risk of bacterial and fungal infections in these patients [1] . Topical antifungal therapy was administered in our case because hyphae and spores were observed upon a direct KOH analysis prepared from the palms and soles of the feet, and also from the nails.
We report this case due to the identification of a novel gene mutation in a patient with mal de Meleda, a palmoplantar keratoderma.
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